Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MBX Biosciences, Inc.(MBX) | 2,136,335 | 2,136,335 | 0 | $117.93M | $125.23M | 44.42% | +$7.31M |
| Avalyn Pharmaceuticals Inc | 2,268,404 | 2,268,404 | 0 | $74.68M | $64.63M | 22.92% | -$10.05M |
| Zenas BioPharma, Inc.(ZBIO) | 1,838,482 | 1,838,482 | 0 | $46.66M | $49.58M | 17.59% | +$2.92M |
| Snowflake Inc.(SNOW) | 114,786 | 114,786 | 0 | $29.21M | $38.98M | 13.82% | +$9.76M |
| Grove Collaborative Holdings, Inc.CL A(GROV) | 3,225,097 | 3,225,097 | 0 | $4.03M | $3.42M | 1.21% | -$612.8K |
| Ondas Inc.(ONDS) | 15,602 | 15,602 | 0 | $128.6K | $114.4K | 0.04% | -$14.2K |
| Omada Health, Inc.(OMDA) | 2,531,000 | 0 | -2,531,000 | $55.56M | $0 | — | -$55.56M |